Swedish Orphan Biovitrum AB (LTS:0MTD)
kr 278.9 -3.1 (-1.1%) Market Cap: 94.14 Bil Enterprise Value: 112.84 Bil PE Ratio: 43.71 PB Ratio: 2.62 GF Score: 88/100

Q3 2022 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Oct 27, 2022 / 11:00AM GMT
Release Date Price: kr204.35 (-3.45%)
Operator

Ladies and gentlemen, welcome to the SOBI Q3 2022 Report. (Operator Instructions) I will now hand over to the company.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Thank you so much. Hello, everybody. This is Guido Oelkers, CEO of SOBI. So we would like to welcome you to the third quarter 2022 report and conference call for investors and analysts. The presentation was posted to sobi.com earlier. And with this, maybe we can move to the second slide.

Slide 2 has the usual safe harbor statement. We'll be making comments on our performance using constant exchange rates or CER, and numbers used in million Swedish krona and for the third quarter of 2022, unless stated otherwise. Comments will be mostly related to the third quarter performance.

Please turn to Slide #3. This is the agenda where we plan to cover all key aspects of the results today. We plan to review the presentation first and then do a Q&A until on to 2:00 p.m. Swedish time or Central European time. We want

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot